Newsletter | April 2, 2026

04.02.26 -- The Hidden Engineering Behind Successful Upstream Bioprocessing

INDUSTRY INSIGHTS

A Comprehensive Solution For Adventitious Agent Testing

Modern sequencing methods offer sensitive detection of adventitious and species‑specific viruses. Learn how targeted and non‑targeted NGS approaches improve confidence in cell bank characterization.

FEATURED EDITORIAL

The Hidden Engineering Behind Successful Upstream Bioprocessing

In upstream biopharmaceutical production, manufacturing is inseparable from biology, engineering, contamination control, and quality science.

New MIT Consortium Links Innovation With Real-World Biomanufacturing

In one area, the Initiative for New Manufacturing is exploring whether microfactories, championed by the EV industry, can help biopharma iterate facility design faster.

5 QMS Blind Spots You Should Know About

Companies often underestimate the complexity of standing up an eQMS. These are five of the most common issues that lead to regulatory and GMP exposure risk.

SOLUTIONS

A High-Capacity Chromatography Resin For Robust mAb Capture